Navigation Links
AutismOnline.org Partners With Leading Health Communications Firm for Support
Date:3/25/2008

Danya Relaunches Site With Expanded Resources for Individuals With Autism and Their Families

SILVER SPRING, Md., March 25 /PRNewswire-USNewswire/ -- Danya International, Inc. (Danya), a health and education communications, research, and technology firm, has acquired AutismOnline.org, a trusted resource for individuals with autism and their families.

AutismOnline links parents and caregivers to support, research, and products in a variety of languages concerning the complex developmental disorder. Approximately 1 in 150 children has a diagnosis of an autism spectrum disorder, which affects the person's ability to communicate and interact with others.

"When a parent has a newly diagnosed child, sifting through hundreds of Web sites can be confusing and time consuming," said Jeff Hoffman, Ph.D., President and CEO of Danya. "It is our hope that in relaunching AutismOnline and continually updating its resources parents will be better served and, in return, will be better able to serve their loved ones with autism."

AutismOnline.org was founded by Ayda Sanver, a parent of a child with autism, and the current Director of the Community Development for CSAAC, a nonprofit agency serving children and adults with autism in Maryland. She approached Danya in 2007 to take over AutismOnline when the site's activity grew beyond what the family and its nonprofit organization could manage.

"We approached Danya because we knew of the company's outstanding reputation for developing educational products that support the emotional and behavioral health of individuals with autism and their families," said Ms. Sanver. "We wanted a socially conscious company to take over the site to ensure that it would have a good home and a successful future."

Danya recently unveiled AutismVision: Creating Classroom Connections, a series of video presentations and school curriculums to help educate the classmates of children and teens with autism and
'/>"/>

SOURCE Danya International
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. International Eye Foundation Announces Partnership with Newport Creative Communications
2. Ochsner Health System Partners with DocuSys for Presurgical Care, AIMS and Medication Management Technology
3. WeissComm Partners Promotes Diane Weiser to President and Chief Operating Officer
4. Kagome Partners With Raise the Hope to Fight Heart Disease
5. HealthMEDX Partners With Silverchair Learning Systems
6. Turner Investment Partners Added to AHA Diversified Equity Fund
7. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
8. ACM Partners With Tufts Associated Health Plans to Improve the Cost-effective Delivery of Home Infusion Services
9. Medicine Disposal Partnership Will Encourage Public to Flush Less, Crush More
10. Country Music Star Troy Gentry Partners With National Non-Profit Patient Advocate Foundation to Spread the Message About Challenges to Healthcare Access for Insured and Uninsured Americans
11. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...hinese children became sick and one death was repo... vaccine.// According to reports about 2,500 child...ered the Hepatitis A vaccine on the 16 and 17 of J... a six-year-old child suffered an unspecified infe...
... organized by women’s magazine, Grazia reported th.../ The survey results reported that an overwhelmin...ndergo cosmetic surgery. The result of the survey ...dy was conducted in 1,000 women in the average age...
...ational study was done involving 598 068 nuclear i... done to estimate the risk of cancer after adminis...nternational collaborative study to estimate the c...the nuclear industry to find out the risk of cance...
...ducted by scientists at Wageningen University, Net...n as Vitamin B6) can slow down the cognitive decli... B9 has been known to help in the brain developmen... a long time now. Due to this reason it is adminis...
Other Medicine News:Health News:Cancer risk among nuclear industry workers 2
(Date:10/8/2008)...ment in patients with pulmonary arterial hype...ve limited benefit for this debilitating, rap...e, -- Imatinib mesylate, available as Gleevec(R...inhibit protein associated with PAH, -- Novarti...e in PAH in 2009 EAST HANOVER, N.J., Oct. 8 ...
(Date:10/7/2008)...exas Cardiac Arrhythmia,Institute (TCAI) at St. Da...nly a few sites in the nation to participate in an...reat persistent atrial fibrillation. TCAI, an,inte...specializing in heart,rhythm disorders, is a partn...s Cardiovascular Consultants., "This is just anot...
(Date:10/7/2008)...-- CEL-SCI Corporation,(NYSE: CVM ) announced tod...reement (MTA) with the National Institutes of Heal...r. Francesco M. Marincola, M.D., to,investigate th...ironment,caused by CEL-SCI,s cancer drug Multikine...ease and Immunogentics Section, Department of Tran...
(Date:10/7/2008)...ligen Therapeutics Inc.,today announced that in vi...dates were presented at the XXII International Com...ighlighted the candidates, efficacy in,several ani...se highlighted presentations, as well as several i...l the deep expertise and expanding,knowledge base ...
Breaking Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Finding the source 3A Cells that initiate a common infant tumor identified 21225 1Brain Stem Cells Reverse Myelin Deficiency in Mice 21223 1Brain Stem Cells Reverse Myelin Deficiency in Mice 21223 2Brain Stem Cells Reverse Myelin Deficiency in Mice 21223 3Impact of Rising Gas Food Prices Felt Globally 21221 1Impact of Rising Gas Food Prices Felt Globally 21221 2Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit 21219 1Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit 21219 2
... ONCONASE for,Treatment of Neuroblastoma, BLOOMFIE...Alfacell Corporation today announced that new data... is active against naive and,chemoresistant neurob...vivo data published in Cancer,Letters (2007; Vol. ...ween Alfacell and Martin Michaelis, M.D., Ph.D., a...
...p; CEO of the Lupus,Foundation of America, Inc., W...- The Lupus,Foundation of America, Inc. and more t...iting the preliminary findings of the Phase,III cl...nt for,lupus kidney disease being tested by Asprev...ments for lupus patients is,critical because many ...
Other Medicine Technology:In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 2In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 3Lupus Foundation of America Statement on Results for Clinical Study,of CellCept Released by Aspreva Pharmaceutical Company 2
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: